Research Use Disclaimer
The peptide protocols referenced on this website are offered exclusively within the context of an Institutional Review Board (IRB)–approved research study. These protocols are investigational in nature and are not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease unless otherwise specifically indicated.
Participation in any research protocol is voluntary and subject to eligibility review, informed consent, and oversight in accordance with established research and ethical guidelines. Information provided on this website is intended for educational purposes only and should not be interpreted as medical advice or as a substitute for consultation with a qualified healthcare professional.
Peptides discussed herein are utilized solely within structured research protocols designed to evaluate safety, tolerability, and/or physiologic response. Individual results may vary, and no guarantees of outcomes are made or implied.
Services provided in connection with research participation may include telehealth-supported screening, study coordination, and ongoing research-related monitoring. Telehealth interactions are conducted for research facilitation purposes and do not replace comprehensive medical care or establish a traditional physician–patient relationship outside the defined scope of the study. If you have questions about your personal health, medical conditions, or current treatments, please consult your licensed healthcare provider.